Table 3.
Adjusted HR (95% CI)a | P | P for interaction | |
---|---|---|---|
All-cause mortality | |||
DASH score (>2 vs. ≤ 2) | |||
Overall population | 0.93 (0.82–1.05) | 0.215 | |
Normal glucose tolerance | 1.02 (0.83–1.24) | 0.874 | 0.168 |
Prediabetes | 0.86 (0.71–1.03) | 0.103 | |
Diabetes | 0.86 (0.71–1.05) | 0.147 | |
aMED (>3 vs. ≤ 3) | |||
Overall population | 0.74 (0.66–0.83) | <0.001 | |
Normal glucose tolerance | 0.75 (0.63–0.89) | 0.002 | 0.777 |
Prediabetes | 0.71 (0.59–0.86) | <0.001 | |
Diabetes | 0.82 (0.66–1.03) | 0.092 | |
CV mortality | |||
DASH score (>2 vs. ≤ 2) | |||
Overall population | 1.00 (0.78–1.28) | 0.995 | |
Normal glucose tolerance | 1.17 (0.77–1.78) | 0.452 | 0.350 |
Prediabetes | 0.91 (0.58–1.44) | 0.694 | |
Diabetes | 0.88 (0.57–1.37) | 0.569 | |
aMED (>3 vs. ≤ 3) | |||
Overall population | 0.81 (0.61–1.07) | 0.135 | |
Normal glucose tolerance | 0.73 (0.50–1.09) | 0.121 | 0.329 |
Prediabetes | 0.76 (0.52–1.11) | 0.152 | |
Diabetes | 1.06 (0.67–1.67) | 0.807 |
aMED, alternative Mediterranean Diet Index; CV, cardiovascular; DASH, Dietary Approaches to Stop Hypertension.
Adjusted for age, sex, race, body mass index, history of hypertension, smoking, total cholesterol, chronic kidney disease, and daily energy intake.